Skip to content

Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin

Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin: a Retrospective Study of Efficacy on Clinical and Isokinetic Criteria

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04004390
Acronym
PPS and IGIV
Enrollment
17
Registered
2019-07-02
Start date
2019-06-28
Completion date
2019-12-30
Last updated
2020-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Poliomyélitis Syndrom

Keywords

Pre- and post-therapeutic evaluation carried out, Data transcribed in the computerized patient file, post-poliomyelitis syndrome, Intravenous immunoglobulins, walking test, isokinetics

Brief summary

Our study evaluates the efficacy of IGIV treatment in PPS on clinical (walking and pain) and isokinetic (muscle strength) criteria, on patients with PS at Montpellier's Hospital

Detailed description

Patients are admitted to a multidisciplinary consultation (neurologist, PMK) to validate the indication of treatment with IGIV. Realization of a pre-therapeutic evaluation in the department of MPR on the criteria of judgment, then the patient is admitted in a service of neurology to benefit from the cure of IGIV. The patient is then re-admitted to a PMR service for post-treatment evaluation. Collection of data retrospectively.

Interventions

None listed

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of PPS * Pre- and post-therapeutic evaluation carried out * Data transcribed in the computerized patient file

Exclusion criteria

* No walking patient

Design outcomes

Primary

MeasureTime frameDescription
Muscular strength5 monthsMuscular strength with isokinetic

Secondary

MeasureTime frameDescription
Walking perimeter5 monthsWalking perimeter with walking test (6 minutes)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026